Delivery Order SPE2DB22D3004-SPE2DB25FQS06
Award Date
5/14/25
Potential Completion Date
6/5/25
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $180,289.20, is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a medication used to treat multiple sclerosis. The contract has a performance period through June 4, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a larger...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OCREVUS 300 mg/10 ml vials, a medication used to treat multiple sclerosis. The contract has a ceiling value of $24,038.58 and is a firm fixed-price delivery order, with a performance period ending on May 21, 2025. The contract is not set aside for any special designation....
This is a $23,118.08 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a prescription medication. Amerisourcebergen, a leading pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $120,192.80 firm fixed-price delivery order contract is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a medication used to treat multiple sclerosis. The contract has a period of performance through May 27, 2025 and is not set aside for any socioeconomic program. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery...
This is a $115,590.40 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to the Corporate Office Division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,564,570,264 units of the drug OCREVUS 300 mg/10 ml vial. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a $84,134.96 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 300 mg/10 mL vials of the drug OCREVUS over a period ending on June 5, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $24,038.58 firm fixed-price delivery order is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a medication used to treat multiple sclerosis. The contract has a ceiling value of $24,038.58 and is a firm fixed-price contract. It was awarded on April 10, 2025, with a completion date of May 1, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a medication, with a ceiling value of $60,096.40 and a period of performance through May 19, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OCREVUS 300 MG/10 ML VIAL 10ML, a medication, with a ceiling value of $12,019.28 and a period of performance through May 27, 2025. This contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...